NCI-CONNECTions: A Rare Brain and Spine Tumor Blog
Read news and information on advances in rare brain and spine tumor research, treatment, and education from our experts.
-
Diagnosing CNS Tumors More Precisely with Methylation MarksMolecular biologist Dr. Zied Abdullaev explains the value of methylation marks for improved accuracy and precision in diagnosing rare brain and spinal cord tumors.
-
Rare Spine Cancer Survivor: “Ain’t Nothin’ Gonna Steal My Joy!”Lynita has lived with ependymoma for 17 years. She shares how she has endured multiple surgeries, radiation, and drug treatments, including an immunotherapy clinical trial, and has adjusted her life to live fully and joyfully with physical limitations.
-
Progress to Advance Care, Treatments and Patient Outcomes for Brain TumorsRead about our advances in care, treatments and patient outcomes for brain and other central nervous systems tumors in honor of Brain Tumor Awareness Month.
-
Neuroradiologist Offers Insight on MRI ScansNeuroradiologist Dr. John Butman has insight and advice on what to expect from brain and spinal cord imaging when you have a cancer diagnosis.
-
New Research Shows How Patients with Brain and Spine Tumors are ImpactedFive nurses share data from the Natural History Study, which aims to better understand brain and spine tumors and uncover areas for further research.
-
Neuro-Oncology Branch Receives Awards at the 2021 SNO Annual MeetingTwo physicians share findings from the NCI-CONNECT Immunotherapy and Natural History Studies in award-winning abstracts.
-
Near-Death Experiences Guided by FaithTom survived a car crash, two bouts of cancer, and an autoimmune disorder. He shares how faith got him through hard times and changed his outlook.
-
Neurosurgeon Values Teamwork for Optimal CareNeurosurgeon Dr. John Heiss shares how his ability to provide the best care for rare brain and spinal cord tumors depends heavily on teamwork, both inside and outside of the operating room.
-
First-in-Human Trial for People with Recurrent Rare CNS TumorsNCI-CONNECT launched a first-in-human phase I clinical trial for people with recurrent rare brain and spine tumors as a first step in the development of a novel drug for patients.
-
New Immunotherapy Study for GlioblastomaA clinical trial investigates immune checkpoint inhibitors with standard treatment in people with aggressive brain cancers to understand the immune system response and improve long-term outcomes.